Systemic Human CR2-Targeted Complement Alternative Pathway Inhibitor Ameliorates Mouse Laser-Induced Choroidal Neovascularization

類似資料

• The alternative pathway is required, but not alone sufficient, for retinal pathology in mouse laser-induced choroidal neovascularization
  著者:: Rohrer, Bärbel, 等
  出版事項: (2011)
• Local Production of the Alternative Pathway Component Factor B Is Sufficient to Promote Laser-Induced Choroidal Neovascularization
  著者:: Schnabolk, Gloriane, 等
  出版事項: (2015)
• New Insights on Complement Inhibitor CD59 in Mouse Laser-Induced Choroidal Neovascularization: Mislocalization After Injury and Targeted Delivery for Protein Replacement
  著者:: Schnabolk, Gloriane, 等
  出版事項: (2017)
• The use of Matrigel combined with encapsulated cell technology to deliver a complement inhibitor in a mouse model of choroidal neovascularization
  著者:: Annamalai, Balasubramaniam, 等
  出版事項: (2020)
• Encapsulated Cell Technology-Based Delivery of a Complement Inhibitor Reduces Choroidal Neovascularization in a Mouse Model
  著者:: Annamalai, Balasubramaniam, 等
  出版事項: (2018)